Asian Pacific Journal of Tropical Biomedicine

ORIGINAL ARTICLE
Year
: 2020  |  Volume : 10  |  Issue : 11  |  Page : 490--495

Polygonatum kingianum rhizome extract alleviates collagen antibody-induced arthritis by modulating proinflammatory cytokine production in mice


Huyen Do Thi Thanh1, Phuong Ngo Thi2, Hien Nguyen Thi Thu3, Nga Nguyen Thi4, Hung Le Ngoc5, Thao Do Thi6, Ha Le Minh1,  
1 Graduate University of Science and Technology; Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi, Vietnam
2 Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi, Vietnam
3 Hanoi Open University101 Nguyen Hien str, Hai Ba Trung Dist., Hanoi, Vietnam
4 Laboratory of Bioassay, Institute of Biotechnology, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi, Vietnam
5 Chemistry Lab Project, Center for Research and Technology transfer, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi, Vietnam
6 Graduate University of Science and Technology; Laboratory of Bioassay, Institute of Biotechnology, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi, Vietnam

Correspondence Address:
Ha Le Minh
Graduate University of Science and Technology; Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Nghia Do, Cau Giay, Hanoi
Vietnam

Abstract

Objective: To evaluate the anti-arthritic effects of Polygonatum kingianum rhizome extract using both in vitro and in vivo models. Methods: Lipopolysaccharide-induced RAW 264.7 macrophages were treated with an ethanol extract of Polygonatum kingianum rhizomes at different concentrations to determine nitric oxide and prostaglandin E2 (PGE2) production. For in vivo study, Polygonatum kingianum ethanol extract was further investigated for its antiinflammatory effect in a mouse model with collagen antibody-induced arthritis. Phytochemical study of Polygonatum kingianum ethanol extract was also performed. Results: Saponins (142 mg/g total yield) was the main component in the Polygonatum kingianum ethanol extract. 5α,8α-ergosterol peroxide, (E,E)-9-oxooctadeca-10,12-dienoic acid and 3-(2’-hydroxy-4’-methoxy-benzyl)-5,7-dihydroxy-8-methyl-chroman-4-one were isolated from the extract. Polygonatum kingianum ethanol extract exhibited potential anti-inflammatory effects by inhibiting nitric oxide and PGE2 production in RAW 264.7 cells in a dose-dependent manner. The level of arthritis in mice with collagen antibody-induced arthritis was significantly reduced (P<0.01) after treatment with Polygonatum kingianum ethanol extract, particularly at a dose of 1 000 mg/kg body weight. Besides, the extract demonstrated the regulatory effects on serum tumor necrosis factor- alpha, interleukin-6, and interleukin-10 in treated mice. Conclusions: Polygonatum kingianum ethanol extract has beneficial effects on inflammatory cytokine regulation and PGE2 inhibition in an experimental mouse model with collagen antibody-induced arthritis. The phytochemical screening reveals that the saponin, as the main component, and sterols (daucosterol and 5α,8α-ergosterol peroxide) from Polygonatum kingianum ethanol extract may contribute to its promising in vitro and in vivo anti-inflammatory activities.



How to cite this article:
Do Thi Thanh H, Ngo Thi P, Nguyen Thi Thu H, Nguyen Thi N, Le Ngoc H, Do Thi T, Le Minh H. Polygonatum kingianum rhizome extract alleviates collagen antibody-induced arthritis by modulating proinflammatory cytokine production in mice.Asian Pac J Trop Biomed 2020;10:490-495


How to cite this URL:
Do Thi Thanh H, Ngo Thi P, Nguyen Thi Thu H, Nguyen Thi N, Le Ngoc H, Do Thi T, Le Minh H. Polygonatum kingianum rhizome extract alleviates collagen antibody-induced arthritis by modulating proinflammatory cytokine production in mice. Asian Pac J Trop Biomed [serial online] 2020 [cited 2020 Dec 2 ];10:490-495
Available from: https://www.apjtb.org/text.asp?2020/10/11/490/294088


Full Text

 1. Introduction



Polygonatum kingianum (P. kingianum) Coll. & Hemsl. (Family: Liliaceae) is a plant distributed across the temperate and subtropical regions of Asia, mainly in China, Laos, and Vietnam[1]. The plant rhizomes have been used in Chinese traditional medicine as a tonic and remedy to treat lung diseases, upset stomachs, diabetes, hyperlipidaemia, related metabolic syndromes, and ringworm[2],[3],[4]. In Vietnam, the plant is a valuable herb for the treatment of tuberculosis, haemoptysis, angina, coronary artery disease, diabetes, hypotension, autonomic nervous system disorders, back pain, joint pain and arthritis including osteoarthritis[1]. Previous phytochemical investigations of this plant’s rhizomes have reported the isolation of steroidal saponins, flavonoids, alkaloids, phenolics, fructose derivatives, and phytosterols[5],[6]. However, very few biological studies on the plant have been published. To date, there are only two reports on the antidiabetic effects of total saponins and the antimicrobial activities of some compounds from P. kingianum[2],[7]. Therefore, additional studies on the biological activities of compounds from this plant should be conducted to explore the usage of the plant in folk medicine. In Vietnamese traditional medicine, the rhizomes of P. kingianum are treated by steaming in hot water and drying before use to enhance their effects and prevent itchiness[1]. In the present paper, we aimed to evaluate the anti-inflammatory effects of an ethanol extract of P. kingianum rhizomes in both in vitro and in vivo models.

 2. Materials and methods



2.1. Preparation of ethanolic extract of P. kingianum rhizomes

The fresh rhizomes of P. kingianum were collected in Ha Giang, Vietnam in September 2017. The scientific name was identified by Dr. Nguyen Van Du, Vietnam Academy of Science and Technology (VAST). The voucher samples (HTHÐ-09.2017) have been deposited at VAST. The fresh rhizomes of P. kingianum were washed, steamed in hot water, and then dried. The process was repeated 9 times until the rhizomes became soft and black according to the processing method used in traditional Vietnamese medicine[1]. The treated rhizomes were sliced and dried in an oven at 40 °C. The obtained dried powder (1.0 kg) was soaked in 95% ethanol (each 4.5 litres, 3 times) at room temperature for 24 h. The extract was then filtered and concentrated under reduced pressure in a rotary evaporator to yield a residue of the ethanol extract (87.5 g, brown solid). The ethanol extract of P. kingianum rhizomes was stored at –20 °C for further phytochemical characterization and pharmacological tests.

The main phytochemical components contained in the ethanol extract of P. kingianum rhizomes were screened (test for terpenoids; sterols, flavonoids; saponins) using standard procedures[8],[9].

2.2. Extraction and isolation of several main compounds from P. kingianum rhizome extract

The ethanol extract of P. kingianum rhizomes (29.4 g) was suspended in water, partitioned with n-hexane, ethyl acetate, n-butanol to obtain fractions: n-hexane (5.2 g), ethyl acetate (15.0 g) and n-butanol (7.0 g). The n-hexane extract (5.2 g) was applied to silica gel CC with n-hexane: ethyl acetate (50:1, v:v) to give five fractions (H1 to H5). Fraction H2 (0.87 g) was firstly subjected to silica gel CC with n-hexane: ethyl acetate (10:1; v:v) and then recrystallized in n-hexane: acetone (4:1; v:v) to yield compound (1) (255 mg). Compound (2) (18 mg) was obtained from fraction H3, silica gel CC, dichloromethane: ethyl acetate (40:1; v:v). The ethyl acetate extract (15.0 g) was subjected to silica gel CC with dichloromethane: ethyl acetate (10:1; v:v) to give five fractions (E1 to E5). Fraction E1 (3.6 g) was subsequently separated using YMC RP-18 CC with methanol: water (1:3, v:v) to yield compound (3) (48 mg). Compound (4) (52 mg) was obtained from fraction E3 by silica gel CC with chloroform: methanol (15:1; v:v). The n-butanol (7.0 g) was dissolved in distilled water (0.1 g/mL) and then purified with D101 macroporous resin. It was washed with distilled water (3 times) to remove polysaccharide and eluted with 85% ethanol eluent (5 times). The eluant was collected and condensed to give 4.2 g of total saponin, the yield was 142.8 mg/g of the ethanol extract of P. kingianum rhizomes.

2.3. Chemicals

Prostaglandin E2 (PGE2), tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10 commercial ELISA kits were purchased from Biovision Inc. (Chester Springs, PA, USA). Lipopolysaccharides (LPS) and all reagents for cell culture were obtained from Sigma-Aldrich Chem. Co. (St. Louis, MO., USA). The anti-collagen antibodies cocktail was provided by Modi Quest Research (Nijmegen, The Netherlands).

2.4. Cell culture and treatment

The RAW 264.7 macrophage cells (ATCC® TIB-71™) were grown in Dulbecco’s Modified Eagle Medium supplemented with 10% fetal bovine serum, 1% antibiotic (Anti-Anti, Sigma-Aldrich Chem. Co.) at 37 °C, 5% CO2 incubation. Cells were subcultured every 2-3 days. To assess nitric oxide (NO) or PGE2 inhibitory activities, 1×105 RAW 264.7 cells in Dulbecco’s Modified Eagle Medium were incubated in the 96-well plates overnight. Different concentrations of the ethanol extract of P. kingianum rhizomes were added into the pre-seeding wells before LPS stimulation for 24 h at 37 °C in a CO2 incubator. The medium suspension was collected for NO and PGE2 determination. The remained cells were used for examining cellular viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay of routine[10]. The Griess assay was used for NO determination[11]. Meanwhile, the PGE2 level in cell medium was measured by the PGE2 kit (Biovision Inc., Chester Springs, PA, USA) following the manufacturer’s guidance.

2.5.Anti-inflammatory evaluation using collagen antibody- induced arthritic mice (CAIA)

Healthy albino BALB/c mice (8–10 weeks old) were obtained from the Institute of Biotechnology, VAST (Hanoi, Vietnam). Mice were housed in a climate-controlled room (25 ± 2) °C with a 12-hour light/12-hour dark cycle. Standard food and water were provided.

To induce CAIA, 24 male BALB/c mice (randomly 10-week-old mice) were injected intraperitoneally (i.p.) with 3 mg of the cocktail of anti-collagen antibodies on day 0 and following with intravenous injection with 25 μg of LPS on day 3 and day 9 to boost arthritic development. Mice having initial symptoms of arthritis on day 4 were divided into 4 groups (6 mice/group). The negative control (group 1) received water daily for 10 d; the treatment groups (groups 2 and 3) were treated with the ethanol extract of P. kingianum rhizomes at doses of 500 and 1 000 mg/kg b.w. daily by intra-gastric gavage for 10 d, respectively; the positive control (group 4) orally received dexamethasone at a dose of 0.5 mg/kg b.w. daily. Due to the results from a previous acute study, which proved that ethanol extracts of P. kingianum rhizomes had no effects on survival rate, body weight, food, or water consumption in mice up to 5 000 mg/ kg b.w., the extract was administered at 500 and 1 000 mg/kg b.w. for the anti-arthritis test. The score of clinical arthritis was recorded depending on the degree of inflammation and swelling[12]. In CAIA, redness and swelling of joints are symptoms used to score arthritis; lower arthritis scores indicate lower arthritic pathogenesis. At the end of the study, the hind paws of 3 experimental mice per group were collected, fixed immediately in 10% neutral formalin for pathological analyses. After decalcifying, all tissues were embedded in paraffin. Finally, 3 mm thickness of joint sections were stained by hematoxylin and eosin (H&E) for histopathological analyses[13]. The production of IL-6, IL-10, and TNF-α in sera of all experimental mice was also measured by using Biovision ELISA kits following the manufacturer’s protocols.

2.6. Statistical analysis

The data were expressed as mean ± standard deviation (SD). Statistical analysis was performed by using GraphPad Prism 5.0 software (GraphPad Software, Inc., San Diego CA). One-way analysis of variance (ANOVA) followed by Bonferroni post-test was applied to compare statistically the difference between the mean of sample and control while two-way ANOVA and Bonferroni post-test was used for comparing among independent groups at diference time points. In all comparisons, P<0.05 was considered statistically significant.

2.7. Ethical statement

The care and use of laboratory animals were executed in conformity with Vietnamese Ethical Laws, European Communities Council Directives of November 24, 1986 (86/609/EEC), guidelines and Approval from Scientific Council of Institute of Biotechnology, VAST dated on January 19, 2019.

 3. Results



3.1. Phytochemical screening of P. kingianum ethanol extracts

Phytochemical screening of P. kingianum ethanol extracts showed that it contained mainly terpenoids, sterols, flavonoids; saponins compounds. Saponins were found to be the main component with a total saponin yield of 142 mg/g of the extract. From P. kingianum ethanol extracts, four compounds were isolated and determined to be 5a,8a-ergosterol peroxide (1); (E,E)-9-oxooctadeca-10,12-dienoic acid (2); 3-(2’-hydroxy-4’-methoxy-benzyl)-5,7-dihydroxy-8-methyl- chroman-4-one (3) and daucosterol (4). Their structures had been elucidated by detailed spectroscopic analyses, including 1D and 2D NMR techniques and along with references (data not shown)[14],[15],[16],[17].

3.2. Effect on NO production

The in vitro anti-inflammatory effects of P. kingianum ethanol extracts on LPS-induced RAW 264.7 macrophages were investigated by measuring NO level. As shown in [Table 1], the NO production was inhibited by P. kingianum ethanol extracts in a dose-dependent manner. The extract at 20 and 100 μg/mL exhibited potential anti-inflammatory properties by clearly inhibiting more than 30% NO production compared with non-treated cells. The extract presented 50% NO inhibition activity (IC50) at (41.68 ± 4.65) μg/mL. However, little effect was observed at the lower concentrations. The ethanol extracts of P. kingianum rhizomes also had minimal impacts on RAW 264.7 cell viability; more than 80% of cells were alive after treatment of 100 μg/mL of the extract for 24 h.{Table 1}

3.3. Effect on PGE2 production

Besides decreased NO production, PGE2 levels were also significantly lower in LPS-induced cells treated with 20 and 100 μg/ mL of ethanol extracts of P. kingianum rhizomes than that of non- treated cells (P<0.01) [Figure 1]. However, at 4 μg/mL, the extract could not inhibit PGE2 secretion.{Figure 1}

3.4. Effect on arthritis score

Based on the promising in vitro anti-inflammatory results, we decided to search for activities of ethanol extracts of P. kingianum rhizomes at an in vivo level using CAIA. In the CAIA model, the joints of mice in the placebo group showed serious inflammatory symptoms, such as red and swollen digits and paws. Arthritis score in this group was gradually increased with time, and at the highest level at day 10. In contrast, starting from day 6, mice exposed to 1 000 mg/kg b.w. of ethanol extracts of P. kingianum rhizomes exhibited a significant reduction in these symptoms and arthritis scores compared with the control (Supplementary Figure). The strong anti-rheumatic activities of the tested extract at this dosage prolonged till the end of the experiment. On the day 14, the arthritis scores in the group treated with ethanol extracts of P. kingianum rhizomes (1 000 mg/kg b.w.) were decreased by nearly 30% compared with the control group [Figure 2]. However, mice in the group treated with 500 mg/kg b.w. of ethanol extracts of P. kingianum rhizomes could not effectively reduce the inflammatory symptoms and arthritic scores at all tested time points.{Figure 2}

3.5. Histopathological results

The histopathology of the joints in the control group revealed strong oedema, inflammatory leukocytes, macrophages, and synovial hyperplasia [Figure 3]. Inflammatory cell infiltration and oedema in the joints were reduced by administration of 1 000 mg/kg b.w. of ethanol extracts of P. kingianum rhizomes.{Figure 3}

3.6. Effect of ethanol extracts of P. kingianum rhizomes on cytokine production

As displayed in [Figure 4]A, 1 000 mg/kg b.w. of ethanol extracts of P. kingianum rhizomes remarkably suppressed the production of TNF-α by almost 48% compared with the vehicle control (P< 0.05). Another proinflammatory cytokine related to arthritis, IL-6, was also evaluated. Administration of the extract repressed IL-6 production in a concentration-dependent manner [Figure 4]B. Of the two experimental doses, 1 000 mg/kg b.w. of the extract significantly and effectively reduced IL-6 secretion into mouse serum compared with the lower dose of 500 mg/kg b.w. Although the ethanol extracts of P. kingianum rhizomes inhibited the production of proinflammatory cytokines such as IL-6 and TNF-α, it had a mild effect on IL-10, an anti-inflammatory cytokine [Figure 4]C (P>0.05).{Figure 4}

 4. Discussion



The phytochemical study of ethanol extracts of P. kingianum rhizomes exhibited the presence of four compounds (1-4), of which compound (1) (5a,8a-ergosterol peroxide) was reported to have antibacterial, anti-inflammatory, antiviral, antioxidant, antitumor and immunosuppressive properties[18]. It is a known compound obtained from a variety of fungi, lichens, sponges, and marine organisms[19]. Some studies also have shown that compound (4) (daucosterol) exhibits anti-inflammatory and immunomodulating activities, promotes the proliferation of neural stem cells, as well as inhibits the proliferation of human breast and gastric cancer cells[20],[21]. Besides, saponins are found to be the main component in this extract which was in consistent with the previous report[22]. The phytochemical screening results suggest that the saponin and sterols (daucosterol and 5a,8a- ergosterol peroxide) may contribute to anti-inflammatory activities of the ethanol extract of P. kingianum rhizomes[23].

In rheumatoid arthritis (RA), the imbalance between two kinds of cytokines, i.e., proinflammatory and anti-inflammatory cytokines, exacerbates the pathogenesis. TNF-α is one of the key proinflammatory mediators involved in RA[24]. The inflammatory response in RA is mediated by the action of TNF-α, which is produced by macrophages, dendritic cells, lymphocytes, and fibroblasts. TNF-α also mediates other elements, such as PGE and proinflammatory cytokines (IL-1 and IL-6), and induces production of granulocyte–monocyte colony-stimulating factor or endothelial leucocyte adhesion molecule-1 via both autocrine and paracrine mechanisms[25],[26]. These elements continuously recruit more inflammatory cells and promote the articular pathology of RA (e.g., bone destruction, cartilage erosion, or pannus formation)[26]. Likewise, IL-6 is a multifunctional cytokine that not only promotes inflammation and articular joint destruction, but also induces systemic symptoms, including inflammatory anaemia, coagulation, and thrombopoietin activation[27]. The levels of both IL-6 and TNF-α are high in the blood of patients with RA[28] and their inhibition has positive effects on RA treatment. Our results showed that the ethanol extracts of P. kingianum rhizomes inhibited IL-6 and TNF-α production, which may have resulted in reduced RA symptoms. Moreover, the extract inhibited in vitro NO production, which is considered a mediator of many inflammatory diseases, including arthritic disorders[29]. As reported elsewhere, NO at micromolar concentrations is associated with pathophysiological mechanisms[11],[30]. Previous studies have suggested that overproduction of NO by inducible nitric oxide synthase is related to inflammatory pathologies, including RA. NO is also overproduced in the inflamed joints of RA patients, suggesting that suppression of NO overproduction may be a target for RA treatment[29]. This result is consistent with previous reports demonstrating NOS inhibition by P. kingianum[7]. Moreover, the ethanol extracts of P. kingianum rhizomes also remarkably inhibited PGE2 production.

In RA pathogenesis, PGE2 is produced during inflammatory processes via responding mediators such as TNF-α and interleukin- 17. The presence of PGE2 exacerbates the symptoms of RA, including osteoclastogenic suppression, pain, and inflammation[31]. According to McCoy et al.[32], PGE2 and other prostanoids are therapeutic targets for RA. Previously, P. kingianum was studied mainly in terms of its effects on diabetic and related diseases, whereas few studies have focused on its anti-inflammatory effects. Thus, the result from our phytochemical study provides evidence to prove that the ethanol extract of P. kingianum rhizomes which contained the reported anti-inflammatory components, presents its anti-arthritic properties and effectiveness.

Conflict of interest statement

The authors declare that there is no conflict of interest.

Funding

This work was supported by the Graduate University of Science and Technology, Vietnam Academy of Science and Technology for financial support (Grant No: GUST.STS.DT 2017-HH13).

Authors’ contributions

HDTT, PNT, and NNT searched the literature and designed the study. Both HNTT and HLN did experiment work. HDTT, TDT, and HLM were responsible for data analysis. HDTT, PNT, TDT, and HLM did preparation, editing, and review of the manuscript.

References

1Bich D, Chung D, Chuong B, Dong N, Dam D, Hien P, et al. Medicinal animals and plants in Vietnam. 1st ed. Hanoi: Hanoi Sci Technol Publ House; 2006.
2Lu JM, Wang YF, Yan HL, Lin P, Gu W, Yu J. Antidiabetic effect of total saponins from Polygonatum kingianum in streptozotocin-induced daibetic rats. J Ethnopharmacol 2016; 179: 291-300.
3Wang YF, Lu CH, Lai GF, Cao JX, Luo SD. A new indolizinone from Polygonatum kingianum. Planta Med 2003; 69(11): 1066-1068.
4Yu HS, Zhang J, Kang LP, Han LF, Zou P, Zhao Y, et al. Three new saponins from the fresh rhizomes of Polygonatum kingianum. Chem Pharm Bull (Tokyo) 2009; 57(1): 1-4.
5Wang YF, Mu TH, Chen JJ, Luo SD. Studies on chemical constituents from the root of Polygonatum kingianum. China J Chin Materia Medica 2003; 28(6): 524-527.
6Li XC, Yang CR, Ichikawa M, Matsuura H, Kasai R, Yamasaki K. Steroid saponins from Polygonatum kingianum. Phytochemistry 1992; 31(10): 3559-3563.
7Yan H, Lu J, Wang Y, Gu W, Yang X, Yu J. Intake of total saponins and polysaccharides from Polygonatum kingianum affects the gut microbiota in diabetic rats. Phytomedicine 2017; 26: 45-54.
8Sofowora A. Medicinal plants and traditional medicine in Africa. Paris: Karthala; 199.
9Trease G, Evans W. Pharmacognosy. 13th ed. London: Bailliere Tindall; 1989.
10Bahuguna A, Khan I, Bajpai VK, Kang SC. MTT assay to evaluate the cytotoxic potential of a drug. Bangladesh J Pharmacol 2017; 12(2): 112-118.
11Cirino G, Distrutti E, Wallace JL. Nitric oxide and inflammation. Inflamm Allergy Drug Targets 2006; 5(2): 115-119.
12Chirivi R, Jenniskens GJ, Raats J. Anti-citrullinated protein antibodies as novel therapeutic drugs in rheumatoid arthritis. J Clin Cell Immunol 2013; 4: 1-13.
13Sim JH, Lee WK, Lee YS, Kang JS. Assessment of collagen antibody-induced arthritis in BALB/c mice using bioimaging analysis and histopathological examination. Lab Anim Res 2016; 32(3): 135-143.
14Gan LS, Chen JJ, Shi MF, Zhou CX. A new homoisoflavanone from the rhizomes of Polygonatum cyrtonema. Nat Prod Commun 2013; 8(5): 597-598.
15Kawagishi H, Miyazawa T, Kume H, Arimoto Y, Inakuma T. Aldehyde dehydrogenase inhibitors from the mushroom Clitocybe clavipes. J Nat Prod 2002; 65(11): 1712-1714.
16Huy DT, Thuy TTT. Some hopanes and esgostanes from lichen Parmotrema sancti – angelii (lynge) hale (Parmeliaceae). J Sci Ho Chi Minh City Uni Educ 2015; 2(67): 13-20.
17Van NTH, Ha L, Phuong N, Anh L, Bach P, Binh N, et al. Some naphthalene lactone relatives from Eleutherine bulbosa in Vietnam. Vietnam J Chem 2012; 51: 30-33.
18Merdivan S, Lindequist U. Ergosterol peroxide: A mushroom-derived compound with promising biological activities-a review. Int J Med Mushrooms 2017; 19(2): 93-105.
19Kim SW, Park SS, Min TJ, Yu KH. Antioxidant activity of ergosterol peroxide (5, 8-epidioxy-5α, 8α-ergosta-6, 22E-dien-3β-ol) in Armillariella mellea. Bull Korean Chem Soc 1999; 20(7): 819-823.
20Jiang LH, Yang NY, Yuan XL, Zou YJ, Zhao FM, Chen JP, et al. Daucosterol promotes the proliferation of neural stem cells. J Steroid Biochem 2014; 140: 90-99.
21Zhao C, She T, Wang L, Su Y, Qu L, Gao Y, et al. Daucosterol inhibits cancer cell proliferation by inducing autophagy through reactive oxygen species-dependent manner. Life Sci 2015; 137: 37-43.
22Yu HS, Ma BP, Kang LP, Zhang T, Jiang FJ, Zhang J, at al. Saponins from the processed rhizomes of Polygonatum kingianum. Chem Pharm Bull (Tokyo) 2009; 57(9): 1011-1014.
23Hassan H, Sule M, Musa A, Musa K, Abubakar M, Hassan A. Anti-inflammatory activity of crude saponin extracts from five Nigerian medicinal plants. Afr J Tradit Complement Altern Med 2012; 9(2): 250-255.
24Lubberts E, van den Berg WB. Cytokines in the pathogenesis of rheumatoid arthritis and collagen-induced arthritis. Adv Exp Med Biol 2003; 520: 194-202.
25Vasanthi P, Nalini G, Rajasekhar G. Role of tumor necrosis factor-alpha in rheumatoid arthritis: A review. APLAR J Rheumatol 2007; 10(4): 270-274.
26Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008; 118(11): 3537-3545.
27Narazaki M, Tanaka T, Kishimoto T. The role and therapeutic targeting of IL-6 in rheumatoid arthritis. Expert Rev Clin Immunol 2017; 13(6): 535-551.
28Srirangan S, Choy EH. The role of interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther Adv Musculoskelet Dis 2010; 2(5): 247-256.
29Dey P, Panga V, Raghunathan S. A cytokine signalling network for the regulation of inducible nitric oxide synthase expression in rheumatoid arthritis. PLoS One 2016; 11(9): e0161306.
30Toledo JC, Augusto O. Connecting the chemical and biological properties of nitric oxide. Chem Res Toxicol 2012; 25(5): 975-989.
31Akaogi J, Nozaki T, Satoh M, Yamada H. Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy. Endocr Metab Immune Disord Drug Targets 2006; 6(4): 383-394.
32McCoy JM, Wicks JR, Audoly LP. The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis. J Clin Invest 2002; 110(5): 651-658.